166 related articles for article (PubMed ID: 37179448)
21. A population-based study of the clinical expression of the hemochromatosis gene.
Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
[TBL] [Abstract][Full Text] [Related]
22. The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype?
Olsson KS; Ritter B; Hansson N
Eur J Haematol; 2007 Nov; 79(5):429-34. PubMed ID: 17924859
[TBL] [Abstract][Full Text] [Related]
23. HLA haplotype map of river valley populations with hemochromatosis traced through five centuries in Central Sweden.
Olsson KS; Ritter B; Hansson N; Chowdhury RR
Eur J Haematol; 2008 Jul; 81(1):36-46. PubMed ID: 18363869
[TBL] [Abstract][Full Text] [Related]
24. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
[TBL] [Abstract][Full Text] [Related]
25. Was the C282Y mutation an Irish Gaelic mutation that the Vikings helped disseminate? HLA haplotype observations of hemochromatosis from the west coast of Sweden.
Olsson KS; Konar J; Dufva IH; Ricksten A; Raha-Chowdhury R
Eur J Haematol; 2011 Jan; 86(1):75-82. PubMed ID: 20946107
[TBL] [Abstract][Full Text] [Related]
26. Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands.
Barton JC; Sawada-Hirai R; Rothenberg BE; Acton RT
Blood Cells Mol Dis; 1999; 25(3-4):147-55. PubMed ID: 10575540
[TBL] [Abstract][Full Text] [Related]
27. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
28. [Iron in the era of molecular biology].
Deugnier Y; Moirand R; Brissot P; David V
Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
[TBL] [Abstract][Full Text] [Related]
29. Hepatic damage in C282Y homozygotes relates to low numbers of CD8+ cells in the liver lobuli.
Cardoso EM; Hagen K; de Sousa M; Hultcrantz R
Eur J Clin Invest; 2001 Jan; 31(1):45-53. PubMed ID: 11168438
[TBL] [Abstract][Full Text] [Related]
30. Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.
Chin J; Powell LW; Ramm LE; Ayonrinde OT; Ramm GA; Olynyk JK
Sci Rep; 2019 Dec; 9(1):20234. PubMed ID: 31882912
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
32. Testing for haemochromatosis in a liver clinic population: relationship between ethnic origin, HFE gene mutations, liver histology and serum iron markers.
Moodie SJ; Ang L; Stenner JM; Finlayson C; Khotari A; Levin GE; Maxwell JD
Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):223-9. PubMed ID: 11953685
[TBL] [Abstract][Full Text] [Related]
33. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.
Barton JC; McLaren CE; Chen WP; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN; Adams PC; Phatak PD; Gurrin LC; Phillips JD; Parker CJ; Emond MJ; McLaren GD
Ann Hepatol; 2018 Aug; 17(5):871-879. PubMed ID: 30145563
[TBL] [Abstract][Full Text] [Related]
34. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload.
Porto G; Cardoso CS; Gordeuk V; Cruz E; Fraga J; Areias J; Oliveira JC; Bravo F; Gangaidzo IT; MacPhail AP; Gomo ZA; Moyo VM; Melo G; Silva C; Justiça B; de Sousa M
Eur J Haematol; 2001 Aug; 67(2):110-8. PubMed ID: 11722599
[TBL] [Abstract][Full Text] [Related]
35. Iron-overload and genotypic expression of HFE mutations H63D/C282Y and transferrin receptor Hin6I and BanI polymorphism in german patients with hereditary haemochromatosis.
Gottschalk R; Seidl C; Schilling S; Braner A; Seifried E; Hoelzer D; Kaltwasser JP
Eur J Immunogenet; 2000 Jun; 27(3):129-34. PubMed ID: 10940080
[TBL] [Abstract][Full Text] [Related]
36. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
[TBL] [Abstract][Full Text] [Related]
37. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
Phatak PD; Barton JC
Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
[TBL] [Abstract][Full Text] [Related]
38. Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE.
Bardou-Jacquet E; Morandeau E; Anderson GJ; Ramm GA; Ramm LE; Morcet J; Bouzille G; Dixon J; Clouston AD; Lainé F; Turlin B; Powell LW; Deugnier YM
Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1851-1857. PubMed ID: 31622736
[TBL] [Abstract][Full Text] [Related]
39. HFE based re-evaluation of heterozygous hemochromatosis.
Moirand R; Guyader D; Mendler MH; Jouanolle AM; Le Gall JY; David V; Brissot P; Deugnier Y
Am J Med Genet; 2002 Sep; 111(4):356-61. PubMed ID: 12210292
[TBL] [Abstract][Full Text] [Related]
40. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
